MedTrace Logo

Vashe Wound Therapy Study

NCT00586729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2012-09-14

Study results available
· View outcomes & findings →

Summary

This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days.

Conditions

  • Burns

Interventions

DEVICE

Vashe

Antimicrobial irrigant

DRUG

Mafenide acetate

Antimicrobial solution

Sponsors & Collaborators

  • PuriCore, Inc.

    collaborator INDUSTRY

  • Valleywise Health

    lead OTHER

Principal Investigators

  • Kevin Foster, MD · District Medical Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00586729 on ClinicalTrials.gov